CompletedPhase 2

Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure

NCT01982292

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Anaheim, California, United States

+51 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2014-05
Enrollment: 321 participants
Sponsor: Novartis Pharmaceuticals

Locations (52)

Novartis Investigative SiteAnaheim, California, United States
Novartis Investigative SiteColorado Springs, Colorado, United States
Novartis Investigative SiteJacksonville, Florida, United States
Novartis Investigative SiteSouth Miami, Florida, United States
Novartis Investigative SiteMinneapolis, Minnesota, United States
Novartis Investigative SiteMinneapolis, Minnesota, United States
Novartis Investigative SiteChapel Hill, North Carolina, United States
Novartis Investigative SiteKnoxville, Tennessee, United States
Novartis Investigative SiteRichmond, Virginia, United States
Novartis Investigative SiteGeelong, Australia
Novartis Investigative SiteMelbourne, Australia
Novartis Investigative SiteBrno-Bohunice, Czech Republic, Czechia
Novartis Investigative SiteJihlava, Czechia
Novartis Investigative SitePrague, Czechia
Novartis Investigative SiteTurku, Finland, Finland
Novartis Investigative SiteLübeck, Germany, Germany
Novartis Investigative SiteHanover, Lower Saxony, Germany
Novartis Investigative SiteBerlin, State of Berlin, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteDresden, Germany
Novartis Investigative SiteFrankfurt, Germany
Novartis Investigative SiteGreifswald, Germany
Novartis Investigative SiteGrünstadt, Germany
Novartis Investigative SiteJena, Germany
Novartis Investigative SiteKiel, Germany
Novartis Investigative SiteMagdeburg, Germany
Novartis Investigative SiteCortona, AR, Italy
Novartis Investigative SiteBrescia, BS, Italy
Novartis Investigative SiteMonza, MB, Italy
Novartis Investigative SiteVimercate, MI, Italy
Novartis Investigative SiteSneek, The Netherlands, Netherlands
Novartis Investigative SiteGroningen, Netherlands
Novartis Investigative SiteRotterdam, Netherlands
Novartis Investigative SiteOslo, Norway
Novartis Investigative SiteTârgu Mureş, Mureș County, Romania
Novartis Investigative SiteBucharest, Romania, Romania
Novartis Investigative SiteBucharest, Romania
Novartis Investigative SiteCraiova, Romania
Novartis Investigative SiteSibiu, Romania
Novartis Investigative SiteMoscow, Russia
Novartis Investigative SiteMoscow, Russia
Novartis Investigative SiteMálaga, Andalusia, Spain
Novartis Investigative SiteSeville, Andalusia, Spain
Novartis Investigative SiteVillamartín, Cadiz, Spain
Novartis Investigative SiteMadrid, Madrid, Spain
Novartis Investigative SiteMadrid, Madrid, Spain
Novartis Investigative SiteStockholm, Sweden
Novartis Investigative SiteDiskapi / Ankara, Turkey (Türkiye)
Novartis Investigative SiteHaydarpasa/Istanbul, Turkey (Türkiye)
Novartis Investigative SiteKocaeli, Turkey (Türkiye)
Novartis Investigative SiteMeselik / Eskisehir, Turkey (Türkiye)
Novartis Investigative SiteSivas, Turkey (Türkiye)